Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic Values of METTL1-Related Genes and Immune Characteristics in Systemic Lupus Erythematosus. | J Inflamm Res | 2023 | 38026241 | PubTator, text mining | PubMed |
| Do RNA modifications contribute to modulation of immune responses in allergic diseases? | Front Allergy | 2023 | 38026133 | PubTator, text mining | PubMed |
| Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer. | PeerJ | 2023 | 38025760 | PubTator, text mining | PubMed |
| N6-methyladenosine of TRIM27 enhances the stem cell-type phenotype of cisplatin-resistant colorectal cancer cells. | Biochem Biophys Rep | 2023 | 38024865 | PubTator, text mining | PubMed |
| m6A epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer. | NAR Cancer | 2023 | 38023731 | PubTator, text mining | PubMed |
| The eighth International Forum on Stem Cells: virtual meeting, October 20-21, 2022. | Blood Sci | 2023 | 38023340 | PubTator, text mining | PubMed |
| m6A regulates breast cancer proliferation and migration through stage-dependent changes in Epithelial to Mesenchymal Transition gene expression. | Front Oncol | 2023 | 38023205 | PubTator, text mining | PubMed |
| PIWIL1 gene polymorphism and pediatric acute lymphoblastic leukemia relapse susceptibility among Chinese children: a five-center case-control study. | Front Oncol | 2023 | 38023199 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia. | Front Immunol | 2023 | 38022588 | PubTator, text mining | PubMed |
| Downregulated M6A modification and expression of circRNA_103239 promoted the progression of glioma by regulating the miR-182-5p/MTSS1 signalling pathway. | J Cancer | 2023 | 38021156 | PubTator, text mining | PubMed |
| m6A demethylase FTO and osteoporosis: potential therapeutic interventions. | Front Cell Dev Biol | 2023 | 38020896 | PubTator, text mining | PubMed |
| m6A modification negatively regulates translation by switching mRNA from polysome to P-body via IGF2BP3. | Mol Cell | 2023 | 38016476 | PubTator, text mining | PubMed |
| Research progress of N6-methyladenosine in colorectal cancer: A review. | Medicine (Baltimore) | 2023 | 38013272 | PubTator, text mining | PubMed |
| Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma. | Cancer Cell Int | 2023 | 38012755 | PubTator, text mining | PubMed |
| ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer. | Cancer Cell Int | 2023 | 38007439 | PubTator, text mining | PubMed |
| The Molecular Impacts of Retrotransposons in Development and Diseases. | Int J Mol Sci | 2023 | 38003607 | PubTator, text mining | PubMed |
| M6A Demethylase Inhibits Osteogenesis of Dental Follicle Stem Cells via Regulating miR-7974/FKBP15 Pathway. | Int J Mol Sci | 2023 | 38003310 | PubTator, text mining | PubMed |
| RNA Splicing in Cancer and Targeted Therapies. | Genes (Basel) | 2023 | 38002963 | PubTator, text mining | PubMed |
| METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway. | Cell Death Dis | 2023 | 38001065 | PubTator, text mining | PubMed |
| Identification of m6A Modification Regulated by Dysregulated circRNAs in Decidua of Recurrent Pregnancy Loss. | Curr Issues Mol Biol | 2023 | 37998728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=37